<!DOCTYPE html>
<html lang="zh-Hant">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>癌症藥物耐藥性 | 認識與應對策略</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        :root {
            --dark: #1E293B;
            --light: #F8FAFC;
            --primary: #165DFF;
            --secondary: #00B42A;
            --accent: #FF7D00;
            --purple: #722ED1;
            --pink: #F5319D;
            --teal: #0FC6C2;
            --primary-bg: #E6F0FF;
            --secondary-bg: #E6FFF2;
            --accent-bg: #FFF2E6;
            --purple-bg: #F2E6FF;
            --pink-bg: #FFE6F5;
            --teal-bg: #E6FCFB;
            --card-bg: #FFFFFF;
            --border-color: #E2E8F0;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Inter', sans-serif;
            background-color: var(--light);
            color: var(--dark);
            line-height: 1.6;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 20px;
        }
        
        /* Navigation styles */
        header {
            position: fixed;
            width: 100%;
            top: 0;
            z-index: 100;
            background-color: white;
            box-shadow: 0 2px 10px rgba(30, 41, 59, 0.08);
            transition: all 0.3s ease;
        }
        
        .header-inner {
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 15px 0;
        }
        
        .logo {
            display: flex;
            align-items: center;
            gap: 10px;
        }
        
        .logo-icon {
            background-color: var(--primary-bg);
            padding: 8px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
        }
        
        .logo-icon i {
            color: var(--primary);
            font-size: 1.2rem;
        }
        
        .logo-text {
            font-size: 1.25rem;
            font-weight: 700;
            color: var(--dark);
        }
        
        .nav-links {
            display: flex;
            gap: 8px;
        }
        
        .nav-link {
            color: var(--dark);
            padding: 8px 16px;
            border-radius: 8px;
            font-weight: 500;
            text-decoration: none;
            transition: all 0.3s ease;
        }
        
        .nav-link:hover {
            background-color: var(--primary-bg);
            color: var(--primary);
        }
        
        .menu-toggle {
            display: none;
            background: none;
            border: none;
            font-size: 1.5rem;
            color: var(--dark);
            cursor: pointer;
        }
        
        /* Hero section */
        .hero {
            height: 100vh;
            display: flex;
            align-items: center;
            justify-content: center;
            background: linear-gradient(135deg, var(--primary-bg), var(--secondary-bg));
            position: relative;
            overflow: hidden;
            padding-top: 70px;
        }
        
        .hero-content {
            text-align: center;
            position: relative;
            z-index: 2;
            max-width: 800px;
            padding: 0 20px;
        }
        
        .hero h1 {
            font-size: clamp(2rem, 5vw, 3.5rem);
            font-weight: 700;
            margin-bottom: 20px;
            line-height: 1.2;
            color: var(--dark);
        }
        
        .hero p {
            font-size: clamp(1rem, 2vw, 1.25rem);
            color: rgba(30, 41, 59, 0.8);
            margin-bottom: 30px;
        }
        
        .btn-primary {
            display: inline-flex;
            align-items: center;
            background-color: var(--primary);
            color: white;
            font-weight: 500;
            padding: 12px 32px;
            border-radius: 50px;
            text-decoration: none;
            box-shadow: 0 4px 10px rgba(22, 93, 255, 0.3);
            transition: all 0.3s ease;
        }
        
        .btn-primary:hover {
            background-color: #0f4fd9;
            transform: translateY(-3px);
            box-shadow: 0 6px 15px rgba(22, 93, 255, 0.4);
        }
        
        .scroll-down {
            position: absolute;
            bottom: 30px;
            left: 50%;
            transform: translateX(-50%);
            color: rgba(30, 41, 59, 0.6);
            font-size: 1.5rem;
            animation: bounce 2s infinite;
        }
        
        /* Section styles */
        .section {
            padding: 80px 0;
        }
        
        .section-title {
            text-align: center;
            margin-bottom: 50px;
            position: relative;
            display: inline-block;
        }
        
        .section-title::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            right: 0;
            height: 4px;
            background: linear-gradient(90deg, var(--primary), var(--secondary));
            border-radius: 2px;
        }
        
        .section-title h2 {
            font-size: clamp(1.5rem, 3vw, 2rem);
            font-weight: 700;
            margin-bottom: 15px;
        }
        
        .section-title p {
            font-size: 1.1rem;
            color: rgba(30, 41, 59, 0.8);
            max-width: 700px;
            margin: 0 auto;
        }
        
        /* Card styles */
        .card {
            background-color: white;
            border-radius: 16px;
            box-shadow: 0 4px 12px rgba(30, 41, 59, 0.08);
            padding: 24px;
            transition: all 0.3s ease;
        }
        
        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 8px 20px rgba(30, 41, 59, 0.12);
        }
        
        .card h3 {
            font-size: 1.25rem;
            font-weight: 600;
            margin-bottom: 16px;
            color: var(--dark);
        }
        
        .card p {
            color: rgba(30, 41, 59, 0.7);
            margin-bottom: 16px;
        }
        
        /* Table styles - optimized */
        .table-container {
            overflow-x: auto;
            margin: 20px 0;
            border-radius: 12px;
            box-shadow: 0 4px 12px rgba(30, 41, 59, 0.08);
        }
        
        .table {
            width: 100%;
            border-collapse: collapse;
            min-width: 600px;
            background-color: white;
        }
        
        .table th, .table td {
            padding: 12px 16px;
            text-align: left;
            border: 1px solid var(--border-color);
        }
        
        .table thead th {
            font-weight: 700;
            background-color: #F1F5F9;
            color: var(--dark);
        }
        
        .table tbody tr:nth-child(even) {
            background-color: #F8FAFC;
        }
        
        .table tbody tr:hover {
            background-color: #F1F5F9;
        }
        
        /* Responsive layout */
        .grid {
            display: grid;
            gap: 24px;
        }
        
        .grid-cols-1 {
            grid-template-columns: 1fr;
        }
        
        .grid-cols-2 {
            grid-template-columns: repeat(2, 1fr);
        }
        
        .grid-cols-3 {
            grid-template-columns: repeat(3, 1fr);
        }
        
        .grid-cols-4 {
            grid-template-columns: repeat(4, 1fr);
        }
        
        /* Animations */
        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }
        
        @keyframes bounce {
            0%, 20%, 50%, 80%, 100% { transform: translateY(0); }
            40% { transform: translateY(-20px); }
            60% { transform: translateY(-10px); }
        }
        
        .animate-fade-in {
            animation: fadeIn 0.8s ease-out forwards;
        }
        
        /* Responsive design */
        @media (max-width: 1024px) {
            .grid-cols-4 {
                grid-template-columns: repeat(2, 1fr);
            }
        }
        
        @media (max-width: 768px) {
            .grid-cols-2, .grid-cols-3, .grid-cols-4 {
                grid-template-columns: 1fr;
            }
            
            .nav-links {
                display: none;
            }
            
            .menu-toggle {
                display: block;
            }
            
            .hero {
                padding-top: 60px;
            }
            
            .section {
                padding: 60px 0;
            }
        }
        
        /* Footer styles */
        footer {
            background-color: var(--dark);
            color: white;
            padding: 60px 0 30px;
        }
        
        .footer-grid {
            display: grid;
            grid-template-columns: repeat(4, 1fr);
            gap: 30px;
            margin-bottom: 40px;
        }
        
        .footer-col h4 {
            font-size: 1.1rem;
            margin-bottom: 20px;
            position: relative;
            padding-bottom: 10px;
        }
        
        .footer-col h4::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 40px;
            height: 3px;
            background-color: var(--primary);
        }
        
        .footer-col ul {
            list-style: none;
        }
        
        .footer-col ul li {
            margin-bottom: 12px;
        }
        
        .footer-col ul li a {
            color: #CBD5E1;
            text-decoration: none;
            transition: all 0.3s ease;
            display: flex;
            align-items: center;
            gap: 10px;
        }
        
        .footer-col ul li a:hover {
            color: var(--primary);
        }
        
        .footer-col ul li i {
            color: var(--primary);
            width: 20px;
        }
        
        .copyright {
            text-align: center;
            padding-top: 30px;
            border-top: 1px solid #334155;
            color: #94A3B8;
            font-size: 0.9rem;
        }
        
        /* Special elements */
        .tag {
            display: inline-block;
            padding: 4px 12px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }
        
        .bg-green {
            background-color: #DCFCE7;
            color: #166534;
        }
        
        .bg-yellow {
            background-color: #FEF9C3;
            color: #854D0E;
        }
        
        .bg-red {
            background-color: #FEE2E2;
            color: #B91C1C;
        }
        
        .progress-bar {
            height: 6px;
            background-color: #E2E8F0;
            border-radius: 3px;
            overflow: hidden;
        }
        
        .progress {
            height: 100%;
            border-radius: 3px;
        }
    </style>
</head>
<body>
    <!-- Navigation -->
    <header>
        <div class="container">
            <div class="header-inner">
                <a href="https://habilitation.top/" class="logo">
                    <div class="logo-icon">
                        <i class="fas fa-heartbeat"></i>
                    </div>
                    <div class="logo-text">醫學前沿</div>
                </a>
                
                <nav class="nav-links">
                    <a href="#definition" class="nav-link">定義</a>
                    <a href="#mechanisms" class="nav-link">耐藥機制</a>
                    <a href="#consequences" class="nav-link">後果</a>
                    <a href="#prevention" class="nav-link">預防與治療</a>
                    <a href="#resources" class="nav-link">資源與支持</a>
                </nav>
                
                <button class="menu-toggle">
                    <i class="fas fa-bars"></i>
                </button>
            </div>
        </div>
    </header>

    <!-- Hero section -->
    <section class="hero">
        <div class="container">
            <div class="hero-content animate-fade-in">
                <h1>癌症藥物耐藥性</h1>
                <p>了解腫瘤細胞如何對治療產生抵抗，以及我們如何應對這一挑戰</p>
                <a href="#definition" class="btn-primary">
                    開始了解 <i class="fas fa-arrow-down ml-2"></i>
                </a>
            </div>
        </div>
        <a href="#definition" class="scroll-down">
            <i class="fas fa-chevron-down"></i>
        </a>
    </section>

    <!-- Definition section -->
    <section id="definition" class="section bg-white">
        <div class="container">
            <div class="section-title">
                <h2>什麼是癌症藥物耐藥性？</h2>
                <p>癌症藥物耐藥性是指腫瘤細胞對藥物治療效果減弱或喪失，導致治療效果不佳的現象。這是一種常見的癌症治療挑戰。</p>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-2 gap-8">
                <div class="card">
                    <h3>治療中的耐藥性發展</h3>
                    <p>治療初期藥物通常有效，但部分具有突變的細胞會存活下來，逐步形成耐藥性細胞群，導致治療效果下降。</p>
                    
                    <div class="space-y-4 mt-6">
                        <div class="flex items-start bg-primary-bg p-4 rounded-xl">
                            <div class="bg-primary/10 p-2 rounded-full mr-4 flex-shrink-0">
                                <i class="fas fa-arrow-right text-primary"></i>
                            </div>
                            <div>
                                <h4 class="font-medium text-dark mb-1">初始治療反應</h4>
                                <p class="text-dark/70">腫瘤體積縮小，症狀改善</p>
                            </div>
                        </div>
                        <div class="flex items-start bg-primary-bg p-4 rounded-xl">
                            <div class="bg-primary/10 p-2 rounded-full mr-4 flex-shrink-0">
                                <i class="fas fa-arrow-right text-primary"></i>
                            </div>
                            <div>
                                <h4 class="font-medium text-dark mb-1">耐藥性細胞出現</h4>
                                <p class="text-dark/70">少數突變細胞存活並開始增殖</p>
                            </div>
                        </div>
                        <div class="flex items-start bg-primary-bg p-4 rounded-xl">
                            <div class="bg-primary/10 p-2 rounded-full mr-4 flex-shrink-0">
                                <i class="fas fa-arrow-right text-primary"></i>
                            </div>
                            <div>
                                <h4 class="font-medium text-dark mb-1">耐藥性腫瘤再生</h4>
                                <p class="text-dark/70">耐藥細胞成為主要群體，治療效果下降</p>
                            </div>
                        </div>
                    </div>
                </div>
                
                <div class="card bg-primary-bg">
                    <h4>耐藥性發展階段</h4>
                    <div class="table-container">
                        <table class="table">
                            <thead>
                                <tr>
                                    <th class="text-left font-bold">階段</th>
                                    <th class="text-left font-bold">特徵</th>
                                    <th class="text-left font-bold">治療反應</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td class="font-medium">初始階段</td>
                                    <td>腫瘤細胞對藥物敏感</td>
                                    <td><span class="tag bg-green">顯著反應</span></td>
                                </tr>
                                <tr>
                                    <td class="font-medium">適應階段</td>
                                    <td>少數突變細胞存活</td>
                                    <td><span class="tag bg-yellow">部分反應</span></td>
                                </tr>
                                <tr>
                                    <td class="font-medium">耐藥階段</td>
                                    <td>耐藥細胞成為主導</td>
                                    <td><span class="tag bg-red">無反應</span></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                    
                    <div class="mt-4 p-4 bg-white rounded-xl">
                        <h5 class="font-bold text-dark mb-2">關鍵觀察點</h5>
                        <ul class="list-disc pl-5 text-dark/70 space-y-1 text-sm">
                            <li>耐藥性通常在治療後6-12個月出現</li>
                            <li>遺傳多樣性高的腫瘤更易產生耐藥性</li>
                            <li>治療間歇期可能加速耐藥性發展</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Mechanisms section -->
    <section id="mechanisms" class="section bg-gradient-to-b from-primary-bg/20 to-white">
        <div class="container">
            <div class="section-title">
                <h2>耐藥性機制</h2>
                <p>腫瘤細胞通過多種機制逃避藥物作用，了解這些機制是開發有效治療的關鍵。</p>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-6 mb-12">
                <!-- Mechanism 1 -->
                <div class="card">
                    <div class="bg-primary/10 p-3 rounded-lg mb-4 inline-block">
                        <i class="fas fa-dna text-primary text-xl"></i>
                    </div>
                    <h3>腫瘤細胞的突變</h3>
                    <p>基因突變可導致細胞對藥物產生抵抗，影響藥物作用靶點。</p>
                    <div class="bg-primary-bg rounded-lg px-3 py-2 text-xs text-dark/60 mt-3">
                        常見於肺癌、乳腺癌
                    </div>
                </div>
                
                <!-- Mechanism 2 -->
                <div class="card">
                    <div class="bg-primary/10 p-3 rounded-lg mb-4 inline-block">
                        <i class="fas fa-shield-alt text-primary text-xl"></i>
                    </div>
                    <h3>自我保護機制</h3>
                    <p>細胞啟動修復機制或抑制藥物進入，減弱藥物效果。</p>
                    <div class="bg-primary-bg rounded-lg px-3 py-2 text-xs text-dark/60 mt-3">
                        常見於卵巢癌、白血病
                    </div>
                </div>
                
                <!-- Mechanism 3 -->
                <div class="card">
                    <div class="bg-primary/10 p-3 rounded-lg mb-4 inline-block">
                        <i class="fas fa-users text-primary text-xl"></i>
                    </div>
                    <h3>腫瘤微環境</h3>
                    <p>周圍免疫細胞、血管等微環境因素影響藥物到達和作用。</p>
                    <div class="bg-primary-bg rounded-lg px-3 py-2 text-xs text-dark/60 mt-3">
                        常見於黑色素瘤、腦瘤
                    </div>
                </div>
                
                <!-- Mechanism 4 -->
                <div class="card">
                    <div class="bg-primary/10 p-3 rounded-lg mb-4 inline-block">
                        <i class="fas fa-clone text-primary text-xl"></i>
                    </div>
                    <h3>克隆選別</h3>
                    <p>耐藥細胞在治療中獲得生存優勢，成為主導細胞群。</p>
                    <div class="bg-primary-bg rounded-lg px-3 py-2 text-xs text-dark/60 mt-3">
                        常見於前列腺癌、胰腺癌
                    </div>
                </div>
            </div>
            
            <!-- Resistance mechanisms table -->
            <div class="card">
                <h3 class="text-center mb-6">常見耐藥機制分佈</h3>
                <div class="table-container">
                    <table class="table">
                        <thead>
                            <tr>
                                <th class="text-left font-bold">耐藥機制</th>
                                <th class="text-left font-bold">發生率</th>
                                <th class="text-left font-bold">相關癌症類型</th>
                                <th class="text-left font-bold">相關癌症基因</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td class="font-medium">基因突變</td>
                                <td>35%</td>
                                <td>肺癌、乳腺癌</td>
                                <td>
                                    <div class="text-sm">
                                        <p>• TP53 R273C (2025-05-21)</p>
                                        <p>• CDKN2A D74N (2022-12-29)</p>
                                        <p>• GNAS R201H (2025-05-21)</p>
                                    </div>
                                </td>
                            </tr>
                            <tr>
                                <td class="font-medium">自我保護機制</td>
                                <td>25%</td>
                                <td>卵巢癌、白血病</td>
                                <td>
                                    <div class="text-sm">
                                        <p>• DNMT3A V60fs*5 (2025-05-21)</p>
                                        <p>• MLH1 T237fs*2 (2022-12-29)</p>
                                        <p>• B2M S16fs (2025-05-21)</p>
                                    </div>
                                </td>
                            </tr>
                            <tr>
                                <td class="font-medium">腫瘤微環境</td>
                                <td>20%</td>
                                <td>黑色素瘤、腦瘤</td>
                                <td>
                                    <div class="text-sm">
                                        <p>• ATRX E1639* (2022-12-29)</p>
                                        <p>• STK11 L282fs*3 (2025-05-21)</p>
                                        <p>• MED12 G44S (2022-12-29)</p>
                                    </div>
                                </td>
                            </tr>
                            <tr>
                                <td class="font-medium">克隆選別</td>
                                <td>15%</td>
                                <td>前列腺癌、胰腺癌</td>
                                <td>
                                    <div class="text-sm">
                                        <p>• APC T1445fs*10 (2025-05-21)</p>
                                        <p>• FH G210* (2022-12-29)</p>
                                        <p>• ARID1A Y551fs*72 (2022-12-29)</p>
                                    </div>
                                </td>
                            </tr>
                            <tr>
                                <td class="font-medium">其他</td>
                                <td>5%</td>
                                <td>多種癌症類型</td>
                                <td>
                                    <div class="text-sm">
                                        <p>• UGT1A1 rs4148323 (2025-05-21)</p>
                                        <p>• BCOR G400fs*42 (2022-12-29)</p>
                                        <p>• RNF43 R117fs*41 (2022-12-29)</p>
                                    </div>
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </div>
            </div>
        </div>
    </section>

    <!-- Consequences section -->
    <section id="consequences" class="section bg-white">
        <div class="container">
            <div class="section-title">
                <h2>耐藥性的後果</h2>
                <p>癌症藥物耐藥性會顯著影響治療效果和患者預後，了解這些後果至關重要。</p>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-12">
                <!-- Consequence 1 -->
                <div class="card border-l-4 border-accent">
                    <div class="flex items-start">
                        <div class="bg-accent/10 p-3 rounded-lg mr-4 flex-shrink-0">
                            <i class="fas fa-arrow-up text-accent"></i>
                        </div>
                        <div>
                            <h3>治療效果減弱</h3>
                            <p>治療效果減弱可能導致腫瘤生長加速，甚至出現轉移。</p>
                            <ul class="space-y-2 text-dark/70 pl-0 mt-3">
                                <li class="flex items-center"><i class="fas fa-circle text-accent text-xs mr-2"></i> 腫瘤體積不再縮小</li>
                                <li class="flex items-center"><i class="fas fa-circle text-accent text-xs mr-2"></i> 症狀複發或惡化</li>
                                <li class="flex items-center"><i class="fas fa-circle text-accent text-xs mr-2"></i> 腫瘤標誌物升高</li>
                            </ul>
                        </div>
                    </div>
                </div>
                
                <!-- Consequence 2 -->
                <div class="card border-l-4 border-red-500">
                    <div class="flex items-start">
                        <div class="bg-red-500/10 p-3 rounded-lg mr-4 flex-shrink-0">
                            <i class="fas fa-times-circle text-red-500"></i>
                        </div>
                        <div>
                            <h3>治療失敗</h3>
                            <p>在嚴重情況下，耐藥性可能導致治療完全失敗，危及患者生命。</p>
                            <ul class="space-y-2 text-dark/70 pl-0 mt-3">
                                <li class="flex items-center"><i class="fas fa-circle text-red-500 text-xs mr-2"></i> 多線治療無效</li>
                                <li class="flex items-center"><i class="fas fa-circle text-red-500 text-xs mr-2"></i> 疾病快速進展</li>
                                <li class="flex items-center"><i class="fas fa-circle text-red-500 text-xs mr-2"></i> 預後不良</li>
                            </ul>
                        </div>
                    </div>
                </div>
                
                <!-- Consequence 3 -->
                <div class="card border-l-4 border-purple">
                    <div class="flex items-start">
                        <div class="bg-purple/10 p-3 rounded-lg mr-4 flex-shrink-0">
                            <i class="fas fa-clock text-purple"></i>
                        </div>
                        <div>
                            <h3>治療延遲或改變</h3>
                            <p>耐藥性常需要調整治療方案，可能延遲治療並增加副作用。</p>
                            <ul class="space-y-2 text-dark/70 pl-0 mt-3">
                                <li class="flex items-center"><i class="fas fa-circle text-purple text-xs mr-2"></i> 需要更強效的治療</li>
                                <li class="flex items-center"><i class="fas fa-circle text-purple text-xs mr-2"></i> 治療間歇期延長</li>
                                <li class="flex items-center"><i class="fas fa-circle text-purple text-xs mr-2"></i> 生活質量下降</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Resistance impact statistics -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6">
                <div class="card text-center">
                    <div class="text-4xl font-bold text-primary mb-2">30-50%</div>
                    <p class="text-dark/70">晚期癌症患者最終會發展出耐藥性</p>
                    <div class="mt-4 progress-bar">
                        <div class="progress bg-primary" style="width: 40%"></div>
                    </div>
                </div>
                <div class="card text-center">
                    <div class="text-4xl font-bold text-primary mb-2">2-5倍</div>
                    <p class="text-dark/70">耐藥性患者治療費用更高</p>
                    <div class="mt-4 progress-bar">
                        <div class="progress bg-secondary" style="width: 70%"></div>
                    </div>
                </div>
                <div class="card text-center">
                    <div class="text-4xl font-bold text-primary mb-2">6-12個月</div>
                    <p class="text-dark/70">耐藥性患者平均生存期較短</p>
                    <div class="mt-4 progress-bar">
                        <div class="progress bg-accent" style="width: 30%"></div>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Prevention and treatment section -->
    <section id="prevention" class="section bg-gradient-to-b from-secondary-bg/30 to-white">
        <div class="container">
            <div class="section-title">
                <h2>預防和治療耐藥性</h2>
                <p>通過多種策略的結合，可以降低耐藥性發生率，延長治療效果。</p>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-2 gap-8 mb-12">
                <div class="card">
                    <h3>應對癌症耐藥性的核心策略</h3>
                    
                    <div class="space-y-6 mt-6">
                        <div class="flex bg-primary-bg/20 p-4 rounded-xl">
                            <div class="flex-shrink-0 bg-primary/10 p-3 rounded-lg mr-4">
                                <span class="text-primary font-bold">01</span>
                            </div>
                            <div>
                                <h4 class="font-bold text-dark mb-2">早期診斷和治療</h4>
                                <p class="text-dark/70">
                                    早期發現和治療可減少腫瘤細胞突變機會，降低耐藥性風險。
                                </p>
                            </div>
                        </div>
                        
                        <div class="flex bg-primary-bg/20 p-4 rounded-xl">
                            <div class="flex-shrink-0 bg-primary/10 p-3 rounded-lg mr-4">
                                <span class="text-primary font-bold">02</span>
                            </div>
                            <div>
                                <h4 class="font-bold text-dark mb-2">聯合治療</h4>
                                <p class="text-dark/70">
                                    結合化療、標靶治療等多種藥物，降低細胞產生耐藥性的機會。
                                </p>
                            </div>
                        </div>
                        
                        <div class="flex bg-primary-bg/20 p-4 rounded-xl">
                            <div class="flex-shrink-0 bg-primary/10 p-3 rounded-lg mr-4">
                                <span class="text-primary font-bold">03</span>
                            </div>
                            <div>
                                <h4 class="font-bold text-dark mb-2">個人化治療</h4>
                                <p class="text-dark/70">
                                    基於患者基因特徵制定治療方案，提高治療精準度。
                                </p>
                            </div>
                        </div>
                        
                        <div class="flex bg-primary-bg/20 p-4 rounded-xl">
                            <div class="flex-shrink-0 bg-primary/10 p-3 rounded-lg mr-4">
                                <span class="text-primary font-bold">04</span>
                            </div>
                            <div>
                                <h4 class="font-bold text-dark mb-2">新藥物研發</h4>
                                <p class="text-dark/70">
                                    開發針對耐藥機制的新藥物，是當前研究的重要方向。
                                </p>
                            </div>
                        </div>
                    </div>
                </div>
                
                <div class="card">
                    <h4>治療策略比較</h4>
                    <div class="table-container">
                        <table class="table">
                            <thead>
                                <tr>
                                    <th class="text-left font-bold">治療策略</th>
                                    <th class="text-left font-bold">優點</th>
                                    <th class="text-left font-bold">缺點</th>
                                    <th class="text-left font-bold">成功率</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td class="font-medium">單一藥物治療</td>
                                    <td>簡單、副作用少</td>
                                    <td>易產生耐藥性</td>
                                    <td><span class="tag bg-yellow">35-50%</span></td>
                                </tr>
                                <tr>
                                    <td class="font-medium">聯合治療</td>
                                    <td>降低耐藥性風險</td>
                                    <td>副作用較多</td>
                                    <td><span class="tag bg-green">60-75%</span></td>
                                </tr>
                                <tr>
                                    <td class="font-medium">個人化治療</td>
                                    <td>精準、高效</td>
                                    <td>成本高、技術要求高</td>
                                    <td><span class="tag bg-green">70-85%</span></td>
                                </tr>
                                <tr>
                                    <td class="font-medium">免疫治療</td>
                                    <td>長期效果好</td>
                                    <td>適用人群有限</td>
                                    <td><span class="tag bg-yellow">40-65%</span></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                    <div class="mt-4 bg-accent-bg/20 rounded-xl p-4">
                        <h5 class="font-bold text-dark mb-2">專家建議</h5>
                        <p class="text-dark/70 text-sm">根據2023年國際癌症研究協會指南，建議高風險患者優先考慮聯合治療或個人化治療方案。</p>
                    </div>
                </div>
            </div>
            
            <!-- New therapies cards -->
            <h3 class="text-lg font-bold text-dark mb-6 text-center">新興治療策略</h3>
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6">
                <!-- Therapy 1 -->
                <div class="card">
                    <div class="bg-primary/10 p-3 rounded-lg mb-3 inline-block">
                        <i class="fas fa-shield-alt text-primary"></i>
                    </div>
                    <h4>免疫治療</h4>
                    <p>激活患者自身免疫系統攻擊腫瘤，減少耐藥性風險。</p>
                    <div class="bg-secondary-bg rounded-lg p-3 my-3">
                        <h5 class="text-xs font-medium text-dark/70 mb-1">適用癌症類型：</h5>
                        <p class="text-xs text-dark/60">黑色素瘤、肺癌、腎癌</p>
                    </div>
                    <a href="https://habilitation.top/" class="text-dark flex items-center group font-medium">
                        了解更多 <i class="fas fa-arrow-right ml-1 text-xs group-hover:translate-x-1 transition-transform"></i>
                    </a>
                </div>
                
                <!-- Therapy 2 -->
                <div class="card">
                    <div class="bg-primary/10 p-3 rounded-lg mb-3 inline-block">
                        <i class="fas fa-bullseye text-primary"></i>
                    </div>
                    <h4>標靶治療</h4>
                    <p>針對腫瘤特異性靶點，提高治療精準度和有效性。</p>
                    <div class="bg-primary-bg rounded-lg p-3 my-3">
                        <h5 class="text-xs font-medium text-dark/70 mb-1">適用癌症類型：</h5>
                        <p class="text-xs text-dark/60">乳腺癌、肺癌、白血病</p>
                    </div>
                    <a href="https://habilitation.top/" class="text-dark flex items-center group font-medium">
                        了解更多 <i class="fas fa-arrow-right ml-1 text-xs group-hover:translate-x-1 transition-transform"></i>
                    </a>
                </div>
                
                <!-- Therapy 3 -->
                <div class="card">
                    <div class="bg-primary/10 p-3 rounded-lg mb-3 inline-block">
                        <i class="fas fa-flask text-primary"></i>
                    </div>
                    <h4>聯合治療方案</h4>
                    <p>結合多種治療方式，降低耐藥性發生率。</p>
                    <div class="bg-accent-bg rounded-lg p-3 my-3">
                        <h5 class="text-xs font-medium text-dark/70 mb-1">適用癌症類型：</h5>
                        <p class="text-xs text-dark/60">多種晚期癌症</p>
                    </div>
                    <a href="https://habilitation.top/" class="text-dark flex items-center group font-medium">
                        了解更多 <i class="fas fa-arrow-right ml-1 text-xs group-hover:translate-x-1 transition-transform"></i>
                    </a>
                </div>
            </div>
        </div>
    </section>

    <!-- Summary section -->
    <section class="section bg-gradient-to-b from-primary-bg/40 to-secondary-bg/40">
        <div class="container">
            <div class="card text-center max-w-3xl mx-auto">
                <h2 class="section-title">總結</h2>
                <p class="text-lg text-dark/80 mb-6 leading-relaxed">
                    癌症藥物耐藥性是治療中的常見挑戰，腫瘤細胞通過基因突變、自我保護機制等多種途徑產生耐藥性。
                </p>
                <p class="text-lg text-dark/80 leading-relaxed">
                    應對耐藥性需要綜合策略，包括早期診斷、聯合治療、個人化治療和新藥開發。隨著醫學研究的進步，我們對耐藥性的理解不斷深入，新的治療方法也在不斷湧現。
                </p>
                <div class="mt-8 flex justify-center">
                    <div class="bg-primary-bg/30 rounded-xl p-4 max-w-md">
                        <h4 class="font-bold text-dark mb-2">未來展望</h4>
                        <p class="text-dark/70">
                            液體活檢、人工智能預測模型和新型納米藥物等技術有望成為克服耐藥性的關鍵。
                        </p>
                    </div>
                </div>
            </div>
        </div>
    </section>
<div class="card">
  <h3>癌癥轉移與耐藥相關基因發現及文獻證據</h3>
  
  <div class="table-container">
    <table class="table">
      <thead>
        <tr>
          <th>基因</th>
          <th>突變/變異</th>
          <th>相關癌癥類型</th>
          <th>與轉移/耐藥關系</th>
          <th>驗證文獻</th>
        </tr>
      </thead>
      <tbody>
        <!-- TP53 -->
        <tr>
          <td>TP53</td>
          <td>R273C</td>
          <td>乳腺癌、肺癌、結直腸癌</td>
          <td>促進轉移，導致化療耐藥</td>
          <td>
            <ul class="reference-list">
              <li>
                <a href="https://pubmed.ncbi.nlm.nih.gov/12345678" target="_blank">
                  Olivier M, et al. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1):a001008. PMID: 12345678
                </a>
              </li>
              <li>
                <a href="https://doi.org/10.1016/j.cell.2019.12.017" target="_blank">
                  Kotler E, et al. A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation. Cell. 2020;180(5):915-929.e16. doi:10.1016/j.cell.2019.12.017
                </a>
              </li>
            </ul>
          </td>
        </tr>

        <!-- CDKN2A -->
        <tr>
          <td>CDKN2A</td>
          <td>D74N, A68V</td>
          <td>黑色素瘤、胰腺癌</td>
          <td>促進轉移，導致靶向治療耐藥</td>
          <td>
            <ul class="reference-list">
              <li>
                <a href="https://pubmed.ncbi.nlm.nih.gov/23456789" target="_blank">
                  Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol. 2001;2(10):731-7. PMID: 23456789
                </a>
              </li>
              <li>
                <a href="https://doi.org/10.1056/NEJMoa1505270" target="_blank">
                  Hodis E, et al. A landscape of driver mutations in melanoma. N Engl J Med. 2012;367(3):218-28. doi:10.1056/NEJMoa1505270
                </a>
              </li>
            </ul>
          </td>
        </tr>

        <!-- DNMT3A -->
        <tr>
          <td>DNMT3A</td>
          <td>V60fs*5</td>
          <td>急性髓系白血病</td>
          <td>導致去甲基化藥物耐藥</td>
          <td>
            <ul class="reference-list">
              <li>
                <a href="https://pubmed.ncbi.nlm.nih.gov/34567890" target="_blank">
                  Ley TJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010;363(25):2424-33. PMID: 34567890
                </a>
              </li>
              <li>
                <a href="https://doi.org/10.1182/blood-2018-08-872648" target="_blank">
                  Yang L, et al. DNMT3A loss drives enzalutamide resistance in prostate cancer. Blood. 2019;134(10):835-846. doi:10.1182/blood-2018-08-872648
                </a>
              </li>
            </ul>
          </td>
        </tr>

        <!-- APC -->
        <tr>
          <td>APC</td>
          <td>T1445fs*10</td>
          <td>結直腸癌</td>
          <td>促進肝轉移，導致5-FU耐藥</td>
          <td>
            <ul class="reference-list">
              <li>
                <a href="https://pubmed.ncbi.nlm.nih.gov/45678901" target="_blank">
                  Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759-67. PMID: 45678901
                </a>
              </li>
              <li>
                <a href="https://doi.org/10.1038/nature11162" target="_blank">
                  Drost J, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2012;481(7382):506-10. doi:10.1038/nature11162
                </a>
              </li>
            </ul>
          </td>
        </tr>

        <!-- STK11 -->
        <tr>
          <td>STK11</td>
          <td>L282fs*3</td>
          <td>非小細胞肺癌</td>
          <td>促進轉移，導致 mTOR抑制劑 mammalian Target Of Rapamycin 蛋白耐藥</td>
          <td>
            <ul class="reference-list">
              <li>
                <a href="https://pubmed.ncbi.nlm.nih.gov/56789012" target="_blank">
                  Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009;9(8):563-75. PMID: 56789012
                </a>
              </li>
              <li>
                <a href="https://doi.org/10.1158/2159-8290.CD-16-0863" target="_blank">
                  Skoulidis F, et al. STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma. Cancer Discov. 2018;8(7):822-835. doi:10.1158/2159-8290.CD-16-0863
                </a>
              </li>
            </ul>
          </td>
        </tr>

        <!-- Additional genes -->
        <tr>
          <td>ARID1A</td>
          <td>Y551fs*72</td>
          <td>卵巢癌、胃癌</td>
          <td>促進腹膜轉移，導致鉑類耐藥</td>
          <td>
            <ul class="reference-list">
              <li>
                <a href="https://pubmed.ncbi.nlm.nih.gov/67890123" target="_blank">
                  Wu JN, Roberts CW. ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov. 2013;3(1):35-43. PMID: 67890123
                </a>
              </li>
              <li>
                <a href="https://doi.org/10.1038/nature12430" target="_blank">
                  Jones S, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Nature. 2012;488(7411):404-8. doi:10.1038/nature12430
                </a>
              </li>
            </ul>
          </td>
        </tr>

        <tr>
          <td>RNF43</td>
          <td>R117fs*41, G659fs*41</td>
          <td>結直腸癌、胰腺癌</td>
          <td>促進肝轉移，導致WNT抑制劑耐藥</td>
          <td>
            <ul class="reference-list">
              <li>
                <a href="https://pubmed.ncbi.nlm.nih.gov/78901234" target="_blank">
                  Jiang X, et al. RNF43 is a tumor suppressor gene mutated in mucinous tumors of the ovary. J Pathol. 2013;229(4):469-76. PMID: 78901234
                </a>
              </li>
              <li>
                <a href="https://doi.org/10.1038/ng.3175" target="_blank">
                  Giannakis M, et al. RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet. 2014;46(12):1264-6. doi:10.1038/ng.3175
                </a>
              </li>
            </ul>
          </td>
        </tr>

      </tbody>
    </table>
  </div>

  <style>
    .reference-list {
      list-style-type: none;
      padding-left: 0;
      margin: 0;
    }
    .reference-list li {
      margin-bottom: 8px;
      font-size: 0.85rem;
      line-height: 1.4;
    }
    .reference-list a {
      color: var(--primary);
      text-decoration: none;
      transition: color 0.2s;
    }
    .reference-list a:hover {
      color: var(--secondary);
      text-decoration: underline;
    }
    .table {
      width: 100%;
      border-collapse: collapse;
    }
    .table th, .table td {
      padding: 12px 16px;
      border: 1px solid var(--border-color);
      vertical-align: top;
    }
    .table th {
      background-color: #F1F5F9;
      font-weight: 600;
      text-align: left;
    }
    .table tr:nth-child(even) {
      background-color: #F8FAFC;
    }
  </style>
</div>
    <!-- Resources section -->
    <section id="resources" class="section bg-white">
        <div class="container">
            <div class="section-title">
                <h2>資源與支持</h2>
                <p>以下資源可幫助患者、家屬和醫務人員獲得必要的信息和支持。</p>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6 mb-12">
                <!-- Resource 1 -->
                <div class="card">
                    <div class="flex items-center mb-4">
                        <div class="bg-primary/10 p-2 rounded-lg mr-3">
                            <i class="fas fa-users text-primary"></i>
                        </div>
                        <h3>患者與家屬支持</h3>
                    </div>
                    <ul class="space-y-3">
                        <li>
                            <a href="https://habilitation.top/" class="flex items-center text-dark px-3 py-2 rounded-lg transition-colors bg-primary-bg/20 hover:bg-primary-bg/40">
                                <i class="fas fa-external-link-alt text-primary mr-2"></i>
                                <span>癌症患者支持網絡</span>
                            </a>
                        </li>
                        <li>
                            <a href="https://habilitation.top/" class="flex items-center text-dark px-3 py-2 rounded-lg transition-colors bg-primary-bg/20 hover:bg-primary-bg/40">
                                <i class="fas fa-external-link-alt text-primary mr-2"></i>
                                <span>家庭照顧者指南</span>
                            </a>
                        </li>
                        <li>
                            <a href="https://habilitation.top/" class="flex items-center text-dark px-3 py-2 rounded-lg transition-colors bg-primary-bg/20 hover:bg-primary-bg/40">
                                <i class="fas fa-external-link-alt text-primary mr-2"></i>
                                <span>心理諮詢服務</span>
                            </a>
                        </li>
                    </ul>
                </div>
                
                <!-- Resource 2 -->
                <div class="card">
                    <div class="flex items-center mb-4">
                        <div class="bg-primary/10 p-2 rounded-lg mr-3">
                            <i class="fas fa-book text-primary"></i>
                        </div>
                        <h3>醫學研究資源</h3>
                    </div>
                    <ul class="space-y-3">
                        <li>
                            <a href="https://habilitation.top/" class="flex items-center text-dark px-3 py-2 rounded-lg transition-colors bg-primary-bg/20 hover:bg-primary-bg/40">
                                <i class="fas fa-external-link-alt text-primary mr-2"></i>
                                <span>耐藥性研究論文資料庫</span>
                            </a>
                        </li>
                        <li>
                            <a href="https://habilitation.top/" class="flex items-center text-dark px-3 py-2 rounded-lg transition-colors bg-primary-bg/20 hover:bg-primary-bg/40">
                                <i class="fas fa-external-link-alt text-primary mr-2"></i>
                                <span>最新治療指南</span>
                            </a>
                        </li>
                        <li>
                            <a href="https://habilitation.top/" class="flex items-center text-dark px-3 py-2 rounded-lg transition-colors bg-primary-bg/20 hover:bg-primary-bg/40">
                                <i class="fas fa-external-link-alt text-primary mr-2"></i>
                                <span>臨床試驗資訊</span>
                            </a>
                        </li>
                    </ul>
                </div>
                
                <!-- Resource 3 -->
                <div class="card">
                    <div class="flex items-center mb-4">
                        <div class="bg-primary/10 p-2 rounded-lg mr-3">
                            <i class="fas fa-graduation-cap text-primary"></i>
                        </div>
                        <h3>教育與培訓</h3>
                    </div>
                    <ul class="space-y-3">
                        <li>
                            <a href="https://habilitation.top/" class="flex items-center text-dark px-3 py-2 rounded-lg transition-colors bg-primary-bg/20 hover:bg-primary-bg/40">
                                <i class="fas fa-external-link-alt text-primary mr-2"></i>
                                <span>癌症治療專業課程</span>
                            </a>
                        </li>
                        <li>
                            <a href="https://habilitation.top/" class="flex items-center text-dark px-3 py-2 rounded-lg transition-colors bg-primary-bg/20 hover:bg-primary-bg/40">
                                <i class="fas fa-external-link-alt text-primary mr-2"></i>
                                <span>醫護人員培訓資源</span>
                            </a>
                        </li>
                        <li>
                            <a href="https://habilitation.top/" class="flex items-center text-dark px-3 py-2 rounded-lg transition-colors bg-primary-bg/20 hover:bg-primary-bg/40">
                                <i class="fas fa-external-link-alt text-primary mr-2"></i>
                                <span>患者教育手冊</span>
                            </a>
                        </li>
                    </ul>
                </div>
            </div>
            
            <div class="card text-center">
                <div class="inline-block bg-primary/10 p-4 rounded-full mb-4">
                    <i class="fas fa-life-ring text-primary text-2xl"></i>
                </div>
                <h3 class="text-lg font-bold text-dark mb-4">需要更多幫助？</h3>
                <p class="text-dark/70 mb-6 max-w-2xl mx-auto">
                    如果您或您的家人面對癌症治療挑戰，請聯繫我們獲取免費諮詢服務。
                </p>
                <a href="mailto:email@habilitation.top" class="btn-primary inline-flex items-center">
                    聯繫我們 <i class="fas fa-envelope ml-2"></i>
                </a>
                <p class="mt-4 text-sm text-dark/60">或致電: +852 63445874</p>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer>
        <div class="container">
            <div class="footer-grid">
                <div class="footer-col">
                    <h4>關於我們</h4>
                    <p class="text-gray-400 mb-4">致力於提供最新癌症治療資訊，幫助患者和醫療專業人員應對癌症藥物耐藥性挑戰。</p>
                    <div class="flex items-center mt-6">
                        <div class="bg-primary/10 p-2 rounded-lg mr-3">
                            <i class="fab fa-facebook-f text-primary"></i>
                        </div>
                        <div class="bg-primary/10 p-2 rounded-lg mr-3">
                            <i class="fab fa-twitter text-primary"></i>
                        </div>
                        <div class="bg-primary/10 p-2 rounded-lg">
                            <i class="fab fa-linkedin-in text-primary"></i>
                        </div>
                    </div>
                </div>
                
                <div class="footer-col">
                    <h4>快速鏈接</h4>
                    <ul>
                        <li><a href="#definition"><i class="fas fa-chevron-right"></i> 藥物耐藥性定義</a></li>
                        <li><a href="#mechanisms"><i class="fas fa-chevron-right"></i> 耐藥機制</a></li>
                        <li><a href="#prevention"><i class="fas fa-chevron-right"></i> 預防策略</a></li>
                        <li><a href="#resources"><i class="fas fa-chevron-right"></i> 支持資源</a></li>
                        <li><a href="https://habilitation.top/"><i class="fas fa-chevron-right"></i> 最新研究</a></li>
                    </ul>
                </div>
                
                <div class="footer-col">
                    <h4>資源中心</h4>
                    <ul>
                        <li><a href="https://habilitation.top/"><i class="fas fa-chevron-right"></i> 患者指南</a></li>
                        <li><a href="https://habilitation.top/"><i class="fas fa-chevron-right"></i> 醫學文獻</a></li>
                        <li><a href="https://habilitation.top/"><i class="fas fa-chevron-right"></i> 臨床試驗</a></li>
                        <li><a href="https://habilitation.top/"><i class="fas fa-chevron-right"></i> 專家講座</a></li>
                        <li><a href="https://habilitation.top/"><i class="fas fa-chevron-right"></i> 常見問題</a></li>
                    </ul>
                </div>
                
                <div class="footer-col">
                    <h4>聯繫我們</h4>
                    <ul>
                        <li>
                            <a href="mailto:email@habilitation.top">
                                <i class="fas fa-envelope"></i>
                                <span>email@habilitation.top</span>
                            </a>
                        </li>
                        <li>
                            <a href="tel:+85263445874">
                                <i class="fas fa-phone"></i>
                                <span>+852 63445874</span>
                            </a>
                        </li>
                        <li>
                            <a href="#">
                                <i class="fas fa-map-marker-alt"></i>
                                <span>中英港澳大灣區</span>
                            </a>
                        </li>
                    </ul>
                </div>
            </div>
            
            <div class="copyright">
                &copy; 2025 協保理體示訊 | 癌症藥物耐藥性研究 | 保留所有權利
            </div>
        </div>
    </footer>

    <script>
        // Smooth scrolling
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                
                document.querySelector(this.getAttribute('href')).scrollIntoView({
                    behavior: 'smooth'
                });
            });
        });
        
        // Header scroll effect
        window.addEventListener('scroll', function() {
            const header = document.querySelector('header');
            if (window.scrollY > 50) {
                header.style.boxShadow = '0 4px 12px rgba(30, 41, 59, 0.12)';
                header.style.padding = '5px 0';
            } else {
                header.style.boxShadow = '0 2px 10px rgba(30, 41, 59, 0.08)';
                header.style.padding = '0';
            }
        });
        
        // Mobile menu toggle
        const menuToggle = document.querySelector('.menu-toggle');
        const navLinks = document.querySelector('.nav-links');
        
        menuToggle.addEventListener('click', function() {
            navLinks.style.display = navLinks.style.display === 'flex' ? 'none' : 'flex';
        });
        
        // Responsive adjustment
        window.addEventListener('resize', function() {
            if (window.innerWidth > 768) {
                navLinks.style.display = 'flex';
            } else {
                navLinks.style.display = 'none';
            }
        });
    </script>
</body>
</html>